Navigation Links
New Monograph Spotlights Urgent Need for Congress to Get Neurotoxins and Other Poisons Out of Vaccines
Date:1/31/2011

WASHINGTON, Jan. 31, 2011 /PRNewswire/ -- With the latest round of flu vaccine damage surfacing in mid-January, the FDA is again investigating the association between vaccines and febrile seizures in children. How often do health consumers need the "wool pulled over their eyes" about vaccines? It's time for Congress to challenge the "safe and effective" mantra of Big Pharma and the medical industry.  

The January 2011 monograph Vaccines & Vaccinations: The Need for Congressional Investigation (edited by Catherine J Frompovich and Laraine C Abbey) documents the presence of toxins, including brain and nervous system damaging adjuvants, excipients, and growth medium in vaccines that can cause health damage to everyone -- especially to children and pregnant women.

The monograph uses peer-reviewed journals, CDC, FDA, HHS, and other accepted sources regarding vaccines/vaccinations to connect the dots on what is NOT being shared with health consumers (nor most health professionals) about vaccinations, e.g., toxic adjuvants like aluminum -- a neurotoxin; mercury -- a neurotoxic hazmat; formaldehyde -- an EPA-declared carcinogen; MSG -- an excitotoxin that stimulates brain cells to self-destruction; polysorbate 80 -- causes infertility in lab rats; diploid (aborted human fetal) cells; foreign DNA from dogs, chicks, monkeys, and insects; plus many more, which should not be injected into babies immediately after birth -- or any time.

One-sixth (1/6th) of U.S. children are neurodevelopmentally damaged, with one in a hundred (1 per 100) victims of autism. Many more children suffer with other chronic health problems, including cancer and autoimmune disorders, both of which have been linked, in part, to vaccines. Autoimmune disorders include diabetes, asthma, and allergies. Such associations must be investigated and not by Big Pharma, who supplies FDA with often-skewed research indicating that neurotoxic adjuvants are "safe."

This monograph delivers much-needed information to legislators, health professionals, and consumers regarding the facts about vaccines.

Pharmaceutical forces driving the vaccine agenda are powerful, but so is the rising tide of concerned professionals and citizens. It is time for Congress to seriously investigate vaccines and vaccinations.

Contact:

Catherine J Frompovich; catherinejfrompovich@ymail.com; 215-653-7575
Laraine C Abbey; betterfoodforbetterkids@yahoo.com; 732-475-2754
Contact either editor by email for a free PDF copy of the 150-page document.



This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Catherine J Frompovich; Laraine C Abbey
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government
2. Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona
3. Total Federal Grant Funds for Indiana Health Information Technology Efforts Climb to Nearly $50 Million; Latest $16 Million Installment Spotlights Indiana Health Information Exchange in Delivering Higher Quality and Higher Value Healthcare Through M
4. Additional Regional Medicare Carrier Initiates Coverage for Posterior Tibial Nerve Stimulation (PTNS) Delivered via Uroplastys Urgent® PC Neuromodulation System
5. Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplastys Urgent® PC Neuromodulation System
6. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
7. Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
8. Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
9. Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
10. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
11. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Texas , Dec. 9, 2016  RxWiki Inc., ... apps, and digital marketing strategies of thousands of pharmacies ... it won Austin Inno,s "50 on Fire" ... "We,re pleased to accept the award as ... Loughlin , Chief Executive Officer at RxWiki. "Our platform ...
(Date:12/9/2016)... Dec. 9, 2016  Forge Therapeutics, Inc. today ... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance ... the treatment of bacterial infections including those caused ... as an attractive antibacterial target for more than ... suitable chemical starting points has hampered its progress. ...
(Date:12/8/2016)... NEW YORK , Dec. 8, 2016 ... ... such as reducing loss of blood during surgeries, lowering the ... surgeries, and decreasing risks of SSIs. The patient warming systems ... and intravascular warming systems.These benefits in turn reduce the stay ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio , ... first national #QuackGivesBack campaign which supported local breast cancer organizations during National Breast ... Quack Gives Back initiative, and we’re very pleased with the participation in ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... , ... December 08, 2016 , ... David J. ... global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, ... the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology ...
Breaking Medicine News(10 mins):